Table 5.
Concentrations of lipids and lipoproteins and lipid and lipoprotein ratios in post-renal transplant (Tx) patients with TG>1500 mg/L and TG<1500 mg/L and the reference group
| Tx patients with TG>1500 mg/L (n=71) | Tx patients with TG<1500 mg/L (n=38) | Reference group (n=89) | |
| TG (mmol/L) | 2.26 (1.77–3.96)***††† | 1.46 (0.51–1.70)*** | 0.93 (0.40–1.70) |
| TC (mmol/L) | 5.20 (3.57–7.23)*† | 4.58 (3.70–6.73) | 4.58 (3.14–5.31) |
| LDL-C (mmol/L) | 3.13 (1.55–5.13)*† | 2.82 (2.20–4.74) | 2.69 (1.32–4.22) |
| HDL-C (mmol/L) | 1.01 (0.64–2.05)*** | 1.08 (0.67–1.99)*** | 1.48 (1.24–2.12) |
| Non-HDL-C (mmol/L) | 4.20 (2.75–6.48)***††† | 3.55 (2.72–5.31)** | 3.13 (1.81–3.50) |
| HDL (mg/L) | 21.1 (10.5–31.1)* | 22.5 (10.5–35.6) | 23.6 (18.5–38.1) |
| ApoAI (mg/L) | 1540 (1070–1990) | 1540 (1220–1990) | 1610 (1380–1860) |
| ApoB (mg/L) | 920 (570–1380)*† | 801 (600–1280) | 740 (600–1180) |
| ApoCIII (mg/L) | 50 (23–90)*** | 41 (22–80)** | 27 (22–33) |
| ApoCIIInonB (mg/L) | 31 (17–65)** | 28 (15–66)** | 19 (15–25) |
| ApoCIII:B (mg/L) | 19 (6–50)***† | 13 (8–30)** | 7 (3–10) |
| ApoE (mg/L) | 57 (37–110) | 51 (30–138) | 49 (35–83) |
| ApoEnonB (mg/L) | 45 (25–84) | 37 (25–105) | 39 (27–49) |
| ApoE:B (mg/L) | 14 (3–55) | 11 (4–38) | 11 (5–24) |
| TC/HDL-C | 5.23 (3.07–9.65)***†† | 4.64 (2.82–6.87)*** | 2.96 (1.20–4.41) |
| LDL-C/HDL-C | 3.22 (1.51–6.86)***† | 2.79 (1.49–4.80)*** | 1.81 (0.80–3.46) |
| TG/HDL-C | 5.11 (2.67–12.35)***††† | 3.20 (0.84–7.86)*** | 1.21 (0.52–2.61) |
| ApoAI/apoB | 1.67 (1.00–2.68)**† | 1.82 (1.24–2.95)* | 2.31 (1.56–2.57) |
| ApoAI/apoCIII | 30.90 (18.10–48.02)***† | 37.50 (18.10–67.05)*** | 58.57 (50.35–67.53) |
| HDL-C/HDL | 18.3 (9.3–42.0)* | 18.7 (10.2–50.4)* | 24.1 (22.3–27.6) |
| HDL-C/apoAI | 0.25 (0.17–0.41)*** | 0.27 (0.19–0.38)*** | 0.35 (0.29–0.37) |
| TG/HDL | 94 (49–249)***††† | 57 (26–131)* | 36 (28–51) |
TG: triglyceride; TC: total cholesterol; LDL: low-density lipoprotein; HDL: high-density lipoprotein; Apo: apolipoprotein. Values are expressed as median (min–max)
*
P<0.05 vs. the reference group
**
P<0.01 vs. the reference group
***
P<0.001 vs. the reference group
†
P<0.05 vs. the Tx patients with TG>1500 mg/L
††
P<0.01 vs. the Tx patients with TG>1500 mg/L
†††
P<0.001 vs. the Tx patients with TG>1500 mg/L